Comparison of Labetalol versus Hydralazin in control of Hypertension in preeclamptic patients and the out come of their pregnancy
Phase 2
- Conditions
- preeclampsia.???, ?????????? ? ???????? ???? ??? ?? ??????, ??? ??? ? ????016-010
- Registration Number
- IRCT201012185414N1
- Lead Sponsor
- Vice chancellor for research, Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 190
Inclusion Criteria
Every pregnant woman by gestational age 20 to 42 weeks with a BP>160/105, singleton, estimated fetal weight < 4500 g
Exclusion criteria:
1. History of basic chronic diseases ,including chronic HTN, hyperthyroidism, arrhythmia
2. Non cephalic presentation, macrosomia, thick meconium, previous history of caesarian section or uterine rupture which abdicate the option of NVD of patients. 3. History of long infertility, stillbirth, anomalous child, every reason for high risk pregnancy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hydralazin effect on control of Hypertension. Timepoint: 20minuts. Method of measurement: Mercurial Barometer.;Labetalol effect on control of Hypertension. Timepoint: 20 minutes. Method of measurement: Mercurial Barometer.
- Secondary Outcome Measures
Name Time Method Maternal pulse rate control. Timepoint: 20minutes. Method of measurement: Maternal pulse rate control.;Average decreased amount of systolic blood pressure after Hydralazin administration. Timepoint: 20 minutes. Method of measurement: Mercurial Barometer.;Average decreased amount of diastolic blood pressure after Hydralazin administration. Timepoint: 20 minutes. Method of measurement: Mercurial Barometer.